TY  - JOUR
AU  - Hernández-García, Marta
AU  - García-Castillo, María
AU  - Bou, Germán
AU  - Cercenado, Emilia
AU  - Delgado-Valverde, Mercedes
AU  - Oliver, Antonio
AU  - Pitart, Cristina
AU  - Rodríguez-Lozano, Jesús
AU  - Tormo, Nuria
AU  - Melo-Cristino, José
AU  - Pinto, Margarida F
AU  - Gonçalves, Elsa
AU  - Alves, Valquíria
AU  - Vieira, Ana Raquel
AU  - Ramalheira, Elmano
AU  - Sancho, Luísa
AU  - Diogo, José
AU  - Ferreira, Rui
AU  - Cruz, Hugo
AU  - Chaves, Catarina
AU  - Duarte, Joana
AU  - Pássaro, Leonor
AU  - Díaz-Regañón, Jazmín
AU  - Cantón, Rafael
PY  - 2022
DO  - 10.1128/spectrum.02927-22
UR  - http://hdl.handle.net/10668/20046
T2  - Microbiology spectrum
AB  - Imipenem-relebactam is a novel β-lactam-β-lactamase inhibitor combination. We evaluated the in vitro activity of imipenem-relebactam and comparators against Enterobacterales clinical isolates recovered in 8 Spanish and 11 Portuguese intensive care...
LA  - en
KW  - ICU patients
KW  - Portugal
KW  - Spain
KW  - carbapenemase-producing Enterobacterales
KW  - imipenem-relebactam susceptibility
KW  - Humans
KW  - beta-Lactamase Inhibitors
KW  - Portugal
KW  - Escherichia coli
KW  - Spain
KW  - Anti-Bacterial Agents
KW  - Imipenem
KW  - Tazobactam
KW  - beta-Lactamases
KW  - Microbial Sensitivity Tests
KW  - Klebsiella pneumoniae
KW  - Drug Combinations
KW  - Intensive Care Units
TI  - Imipenem-Relebactam Susceptibility in Enterobacterales Isolates Recovered from ICU Patients from Spain and Portugal (SUPERIOR and STEP Studies).
TY  - research article
VL  - 10
ER  -